a downgrade or comments from an analyst? TIA and good luck to all longs.
A matter of time before one or all of those things come true. NFLX going much higher. GLTAL and go NFLX!!!!!
Thanks for the laughs, now off to the sandbox for you.
is that all about. AAPL should be over 130 right now. Total BS
on 3/12 BofA/Merrill reiterated SWKS with a buy and a share price target of $110.00. It is not too late to get in. SWKS has their hands in the fastest growing areas of the economy. Long and strong SWKS.
ACAD must be having some excellent data being conveyed. Long and strong ACAD. Onward and upward to $50 and beyond.
in the low 90's with more to buy if it goes lower.
someone wants in at the market price since there is heavy buying on the offer. GLTAL
• ZIOPHARM (ZIOP 11.26) target raised to $14 from $11 at Mizuho. Firm notes their DCF has been adjusted, adding the CAR/TCR program to their model. As details emerge they will adjust the discount rate/probability of success. They view the combination of ZIOP and MD Anderson in CAR/TCR as compelling, potentially differentiated but still early. Catalysts that help reiterate their Buy are 1) trial initiations in the CAR/TCR space, 2) potential data from one or more clinical programs by year-end, and 3) updates to the IL-12 program.